ecancermedicalscience

Submit article

https://doi.org/10.3332/ecancer.2018.802

Abstract | Full Article |

Review

A systematic review of the literature exploring the interplay between prostate cancer and type two diabetes mellitus

25 Jan 2018

Danielle Crawley, Florence Chamberlain, Hans Garmo, Sarah Rudman, Björn Zethelius, Lars Holmberg, Jan Adolfsson, Par Stattin, Paul Carroll, Mieke Van Hemelrijck

Prostate cancer (PCa) and type two diabetes mellitus (T2DM) are both increasing prevalent conditions and often occur concurrently. However, the relationship between the two is more complex than just two prevalent conditions co-existing. This review systematically explores the literature around the interplay between the two conditions. It covers the impact of pre-existing T2DM on PCa incidence, grade and stage, as well as exploring the impact of T2DM on PCa outcomes and mortality and the interaction between T2DM and PCa treatments.

Article metrics: 2710 views

996

1714

2246-intended-and-completed-treatment-pathways-in-non-metastatic-oesophageal-cancer-treated-with-chemoradiotherapy-real-world-survival-and-swallowing-outcomes

Research: Intended and completed treatment pathways in non-metastatic oesophageal cancer treated with chemoradiotherapy: real-world survival and swallowing outcomes

Nikhil Bathija, Rohit Mahajan, Anil Kumar Goel, Siva Ranjani, Mounika Sirimalla, Gourav Kaushal, Sapna Marcus, Shilpa Jain, Madhur Verma, Deep Shikha, Korukonda Vinod Kumar, Jyoti Sharma

10 Nov 2026

https://doi.org/10.3332/ecancer.2026.2246

Abstract | Full Article | PDF

2245-high-burden-of-germline-variants-of-uncertain-significance-in-advanced-renal-cell-carcinoma-insights-from-an-indian-cohort

Research: High burden of germline variants of uncertain significance in advanced renal cell carcinoma: insights from an Indian cohort

Pavan Raju Kola, Amith Paruchuri, Nimisha Preman, Hemavathi Baskarane, Vishakha Hooda, Aparna Sharma, Ishaan Gupta, Saran Kumar, Shilpi Minocha, Pranay Tanwar, Mohit Kumar Divakar, Atul Batra

5 Nov 2026

https://doi.org/10.3332/ecancer.2026.2245

Abstract | Full Article | PDF

2238-retrospective-analysis-of-patients-with-locally-advanced-or-metastatic-urothelial-carcinoma-treated-in-argentina-2018-2025-results-from-the-guia-2-study-in-real-world-clinical-practice

Research: Retrospective analysis of patients with locally advanced or metastatic urothelial carcinoma treated in Argentina (2018–2025): results from the GUIA 2 study in real-world clinical practice

Pablo Companys, Tomas Soule, Mariano Aymar, María Natalia Gandur Quiroga, Rosalía Hinojosa Altamirano, Marcelo Fogtman, Augusto Ferreyra Camacho, Rodrigo Sánchez, Gonzalo Taetti, Gabriela Gatica, Natalia Soto, María Elisa Arroyo, Nicolas Mainardi, Carolina Passarella, Andrea Marchioni, Ignacio Jerez, María Pía Domínguez, Emiliano Menna, Harold Somerville, Ernesto Korbenfeld, Florencia Sarru, Karina Peters, Iván Macharashvili, Federico Losco, Laura Pelagatti Santoni, Mauricio Fernández Lazaro, José Zarba, Mabel Gill, Juan Pablo Sade, Federico Cayol

21 Oct 2026

https://doi.org/10.3332/ecancer.2026.2238

Abstract | Full Article | PDF

2234-bevacizumab-in-advanced-hepatocellular-carcinoma-outside-clinical-trials-consensus-recommendations

Research: Bevacizumab in advanced hepatocellular carcinoma outside clinical trials: consensus recommendations

Leonardo G Da Fonseca, Duilio Reis da Rocha Filho, Aline Lopes Chagas, Alexandre Jacome, Leila Moreira Beltrao Pereira, Rogerio Alves, Mario Reis Alvares-da-Silva, Mauro Donadio, Ana Paula Victorino, Federico Piñero, Cassia Guedes Leal

15 Oct 2026

https://doi.org/10.3332/ecancer.2026.2234

Abstract | Full Article | PDF